The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019
Abstract
BACKGROUND Skin cancer is the most common cancer worldwide. OBJECTIVE To evaluate burden of skin cancer in the US from 1990 to 2019. METHODS Age-standardized incidence, prevalence, disability adjusted life years (DALY) and mortality rates from skin cancer in the US were evaluated from the Global Burden of Disease (GBD) 2019. RESULTS Incidence, prevalence, DALY and mortality rates per 100,000 persons from melanoma in 2019 were 17.0, 138, 64.8 and 2.2, respectively; for squamous cell carcinoma (SCC) were 262, 314, 26.6 and 0.8, respectively; and for basal cell carcinoma were 525, 51.2, 0.2 and zero, respectively. Incidence as well as prevalence rates of melanoma and non-melanoma skin cancer (NMSC) have increased since 1990. Mortality rates from melanoma and NMSC have remained fairly stable. Males have had a higher incidence, prevalence, DALY and mortality rate from melanoma as well as from NMSC every year since 1990. Incidence and prevalence of melanoma was relatively higher in the northern half of the US than in the southern half. LIMITATIONS GBD is derived from estimation and mathematical modeling. CONCLUSIONS Healthcare professionals can utilize differences and trends noted in this study to guide allocation of resources in order to reduce incidence and morbidity from skin cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Wang, H., Abbas, K. M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abolhassani, H., Abreu, L. G., Abrigo, M. R. M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30977-6 · Cited by 1,971
Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002−2006 and 2007−2011
Guy, G. P., Machlin, S. R., Ekwueme, D. U., & Yabroff, K. R. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.08.036 · Cited by 873
Karia, P. S., Han, J., & Schmults, C. D. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.11.037 · Cited by 829
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013
Karimkhani, C., Dellavalle, R. P., Coffeng, L. E., Flohr, C., Hay, R. J., Langan, S. M., Nsoesie, E. O., Ferrari, A. J., Erskine, H. E., Silverberg, J. I., et al. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.5538 · Cited by 742
Five insights from the Global Burden of Disease Study 2019
Murray, C. J. L., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasi-Kangevari, M., Abd-Allah, F., Abdollahi, M., Abedi, P., Abedi, A., Abolhassani, H., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31404-5 · Cited by 675
van Rossum, G. (2006) · USENIX Annual Technical Conference · Cited by 581
Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.
Guy, G. P., Thomas, C. C., Thompson, T., Watson, M., Massetti, G. M., & Richardson, L. C. (2015) · PubMed Central · Cited by 567
Cited by
Hasan, N., Nadaf, A., Imran, M., Jiba, U., Sheikh, A., Almalki, W. H., Almujri, S. S., Mohammed, Y. H., Kesharwani, P., & Ahmad, F. J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01854-3 · Cited by 322
Overview of skin cancer types and prevalence rates across continents
Roky, A. H., Islam, M. M., Ahasan, A. M. F., Mostaq, M. S., Mahmud, M. Z., Amin, M. N., & Mahmud, M. A. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.08.002 · Cited by 239
Yamamoto, A. L. C., Corrêa, M. D. P., Torres, R. R., Martins, F. B., & Godin-Beekmann, S. (2024) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-024-00594-7 · Cited by 7
Olsen, C. M., Pandeya, N., Neale, R. E., & Whiteman, D. C. (2024) · Medical Journal of Australia · doi:10.5694/mja2.52293 · Cited by 3
Metadata
- Authors
- Aggarwal, P., Knabel, P., & Fleischer, A. B.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 85
- Issue
- 2
- Pages
- 388-395
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W3153120921
- Cited by
- 283
- References
- 29
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. https://app.cochat.ai/papers/10.1016/j.jaad.2021.03.109
- The paper
- Aggarwal, P., Knabel, P., & Fleischer, A. B. (2021). United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2021.03.109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.